pharma · Autoimmune Epilepsy · OPTN
Option Therapeutics
Option Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
CARSON CITY, NV, USA HQ
2023 Founded
2 Employees
Public company Type
OPTN · NYSE Ticker
Company details
- Status
- Public
- HQ
- CARSON CITY, NV, USA
- Founded
- 2023
- Employees
- 2
- Programs
- 1
- Drugs
- 1
- Patents
- 10
Option Therapeutics projects
0 ClinicalTrials.gov programs sponsored by Option Therapeutics.
Option Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Option Therapeutics have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.